Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

507 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and safety of mogamulizumab for the treatment of Sézary syndrome in very elderly patients: A real-world, multicentre, retrospective study conducted in France.
Ribereau-Gayon E, Beylot-Barry M, De Masson A, Ram-Wolff C, Bagot M, Pham-Ledard A, Grange F. Ribereau-Gayon E, et al. Among authors: de masson a. J Eur Acad Dermatol Venereol. 2024 May 28. doi: 10.1111/jdv.20127. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38804019 No abstract available.
Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study).
Tzoumpa S, Ingen-Housz-Oro S, de Masson A, Pham-Ledard A, El Aarbaoui T, Dereure O, Quereux G, Faiz S, de Vicq de Cumptich M, Ram-Wolff C, Janela-Lapert R, Guenova E, Lheure C, Le Corre Y, Adamski H, Blanchard M, Bonnet N, Amatore F, Grange F, Troin L, Bagot M, Beylot-Barry M. Tzoumpa S, et al. Among authors: de masson a. Br J Dermatol. 2024 Apr 25:ljae153. doi: 10.1093/bjd/ljae153. Online ahead of print. Br J Dermatol. 2024. PMID: 38660811 No abstract available.
Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms.
Mahévas T, Osio A, Larcher L, Clappier E, Kempf W, Adès L, Fenaux P, Sébert M, Delaleu J, Jachiet M, Cordoliani F, Charvet E, Carpentier O, Itzykson RA, Weinborn M, Mardare N, Marco-Bonnet J, de Masson A, Duployez N, Huynh T, Bouaziz JD, Vignon-Pennamen MD, Battistella M. Mahévas T, et al. Among authors: de masson a. Blood Adv. 2024 Apr 12:bloodadvances.2023012489. doi: 10.1182/bloodadvances.2023012489. Online ahead of print. Blood Adv. 2024. PMID: 38621250 No abstract available.
CD39 is expressed by a wide range of cutaneous T-cell lymphomas.
Battesti G, Thonnart N, Bozonnat A, Ram-Wolff C, de Masson A, Bensussan A, Bagot M, Marie-Cardine A, Battistella M. Battesti G, et al. Among authors: de masson a. Skin Health Dis. 2024 Jan 10;4(2):e334. doi: 10.1002/ski2.334. eCollection 2024 Apr. Skin Health Dis. 2024. PMID: 38577051 Free PMC article.
Targeting TGF-β Activation in Cutaneous T-Cell Lymphomas.
Giustiniani J, Ta VA, Belkhelouat S, Battistella M, Ouahbi D, Ram-Wolff C, Louveau B, Mourah S, Bagot M, Moins-Teisserenc H, Ortonne N, Bensussan A, De Masson A. Giustiniani J, et al. Among authors: de masson a. J Invest Dermatol. 2024 Mar 28:S0022-202X(24)00259-8. doi: 10.1016/j.jid.2024.03.019. Online ahead of print. J Invest Dermatol. 2024. PMID: 38555062 Free article. No abstract available.
507 results